Orchid Pharma Ltd.
BSE: 524372 | Sector: Health care |
NSE: ORCHPHARMA | ISIN Code: INE191A01027 |
BSE 00:00 | 31 Jan | 344.30 |
12.75 (3.85%) |
OPEN
339.50 |
HIGH
344.65 |
LOW
336.70 |
NSE 00:00 | 31 Jan | 344.95 |
10.75 (3.22%) |
OPEN
339.00 |
HIGH
348.85 |
LOW
335.10 |
OPEN | 339.50 |
PREVIOUS CLOSE | 331.55 |
VOLUME | 244 |
52-Week high | 438.50 |
52-Week low | 260.20 |
P/E | |
Mkt Cap.(Rs cr) | 1,405 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Orchid Pharma Ltd. (ORCHPHARMA) - Financial Overview
Particulars (![]() |
2022 | 2021 | 2020 |
Net Sales | 556.97 | 450.70 | 481.21 |
Operating Profit | 115.67 | 43.96 | -25.71 |
Other Income | 56.97 | 6.46 | 24.28 |
Interest | 33.46 | 52.21 | 6.22 |
Depreciation | 87.02 | 108.90 | 117.91 |
Profit Before Tax | -4.81 | -117.15 | -149.84 |
Tax | 0.00 | 0.00 | 0.00 |
Profit After Tax | -4.81 | -117.15 | -149.84 |
Share Capital | 40.82 | 40.82 | 40.82 |
Reserves | 637.14 | 640.52 | 757.01 |
Net Worth | 677.96 | 681.34 | 797.83 |
Loans | 278.97 | 464.28 | 578.18 |
Gross Block | 1176.26 | 1175.97 | 1246.98 |
Investments | 49.01 | 15.43 | 0.34 |
Cash | 4.21 | 18.97 | 172.32 |
Debtors | 160.23 | 131.96 | 66.38 |
Net Working Capital | 314.47 | 452.38 | 492.20 |
Operating Profit Margin (%) | 20.77 | 9.75 | -5.34 |
Net Profit Margin (%) | -0.86 | -25.99 | -31.14 |
Earning Per Share (Rs) | -1.18 | -28.70 | -36.71 |
Dividend (%) | 0.00 | 0.00 | 0.00 |
Dividend Payout | 0.00 | 0.00 | 0.00 |
Quick Links for Orchid Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices